Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of the NF-κB pathway (124), and Wy14643 shows toxicity to breast cancer cells via PPARα–CYP1B1 expression (125), suggesting the therapy potential of PPARα in breast cancer. Here, PPARA is linked to breast carcinoma.